Antibody Responses to Bordetella pertussis Fim2 or Fim3 following Immunization with a Whole-Cell, Two-Component, or Five-Component Acellular Pertussis Vaccine and following Pertussis Disease in Children in Sweden in 1997 and 2007

Comparative Effectiveness of Acellular Versus Whole-Cell Pertussis Vaccines in Teenagers

(2013) N. P. Klein et al.   PEDIATRICS

Waning Immunity to Pertussis Following 5 Doses of DTaP

(2013) S. Y. Tartof et al.   PEDIATRICS

Antibody Responses to Individual Bordetella pertussis Fimbrial Antigen Fim2 or Fim3 following Immunization with the Five-Component Acellular Pertussis Vaccine or to Pertussis Disease

(2012) Frances Alexander et al.   Clinical and Vaccine Immunology

Is adolescent pertussis vaccination preferable to natural booster infections?

(2011) Hans O Hallander et al.   Expert Review of Clinical Pharmacology

Antibody Response Patterns to Bordetella pertussis Antigens in Vaccinated (Primed) and Unvaccinated (Unprimed) Young Children with Pertussis

(2010) J. D. Cherry et al.   Clinical and Vaccine Immunology

Novel architectural features of Bordetella pertussis fimbrial subunit promoters and their activation by the global virulence regulator BvgA

(2010) Qing Chen et al.   MOLECULAR MICROBIOLOGY

Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection

(2009) HANS O. HALLANDER et al.   APMIS

Bordetella pertussisstrain variation and evolution postvaccination

(2009) Teemu Kallonen et al.   Expert Review of Vaccines

Changes in Genetic Diversity of the Bordetella pertussis Population in the United Kingdom between 1920 and 2006 Reflect Vaccination Coverage and Emergence of a Single Dominant Clonal Type

(2009) D. J. Litt et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Bordetella pertussis Isolates in Finland: Serotype and Fimbrial Expression

(2008) Eriikka Heikkinen et al.   BMC MICROBIOLOGY